United States Physiological Saline Market Insights Forecasts to 2033

• The United States Physiological Saline Market Size was valued at USD 2.56 Billion in 2023.
• The Market is Growing at a CAGR of 6.13% from 2023 to 2033
• The U.S. Physiological Saline Market Size is expected to reach USD 4.64 Billion by 2033

The United States Physiological Saline Market Size is anticipated to exceed USD 4.64 Billion by 2033, Growing at a CAGR of 6.13% from 2023 to 2033. The growing prevalence of serious illnesses and fluid electrolyte disorders are driving the growth of the physiological saline market in the United States.     

Market Overview

Physiological saline is a sterile solution that serves as a source of electrolytes and helps maintain body fluid balance. It closely resembles the composition of bodily fluids, particularly extracellular fluid, composed of 0.9% sodium chloride (NaCl) dissolved in water. This composition makes it isotonic and compatible with the physiological conditions of the body. It has extensive clinical applications including intravenous fluid replacement, hydration therapy, medication administration, and wound irrigation. The widespread application of physiological saline in different clinical settings surges the large-scale saline solution requirements in hospital settings which are likely to expand the market demand. Further, the increasing awareness of less expensive and readily available saline solutions such as phosphate-buffered saline solutions for use in the transportation of medical specimens is likely to leverage market opportunity for physiological saline.

Report Coverage

This research report categorizes the market for the US physiological saline market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the physiological saline market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the physiological saline market.

Driving Factors

The growing prevalence of serious illnesses such as cancer, diabetes, and cardiovascular conditions is fueling the market demand for physiological saline. The surging need for sterile saline for wound irrigation and hydration due to increasing surgical procedures is contributing to driving the market. The high medical and healthcare applications as well as the adoption of saline solution due to product safety and availability are also responsible for driving the market growth. Furthermore, the surging demand for fluid electrolytes in the elderly population is driving the physiological saline market.

Restraining Factors

The adverse effects associated with the rapid isotonic saline infusion hinder the market growth for physiological saline in the US.

Market Segmentation

The United States Physiological Saline Market share is classified into type, packaging type, route of administration, and application.

• The normal saline segment dominated the market with the largest market share in 2023.

The United States physiological saline market is segmented by type into normal saline, hypertonic saline, hypotonic saline, and balanced saline. Among these, the normal saline segment dominated the market with the largest market share in 2023. Normal saline solutions are used for short-term fluid replacement, restoring electrolyte/salt levels in the body, and treating dehydration. It is used to maintain electrolyte disturbances like mild sodium depletion and metabolic alkalosis.

• The plastic bottles segment accounted for the largest share of the United States physiological saline market in 2023.       

Based on the packaging type, the United States physiological saline market is divided into flexible bag, plastic bottles, and glass bottles. Among these, the plastic bottles segment accounted for the largest share of the United States physiological saline market in 2023. Plastic bottles have biologically proven safe packaging material and are convenient to operate. It can be used for normal intravenous injection, sputum suction by connecting sputum suction pipe, and for adding medicine by using the needlepoint.

• The intravenous segment is predicted to grow at the fastest CAGR over the forecast period.       

Based on the route of administration, the United States physiological saline market is divided into intravenous and topical. Among these, the intravenous segment is predicted to grow at the fastest CAGR over the forecast period. The intravenous saline solution is a simple, safe, and common procedure with a low risk of complications. It is used to manage acutely ill or injured patients. By administrating saline solution via the intravenous route, patients may feel relief in a short span.

• The intravenous segment is expected to witness the fastest CAGR growth during the forecast period.       

Based on the application, the United States physiological saline market is divided into intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. Among these, the intravenous segment is expected to witness the fastest CAGR growth during the forecast period. Intravenous saline solutions are designed to prevent or treat dehydration as well as for patients who are ill, injured, or having surgery. Saline intravenous bags provide a rapid and targeted solution to replenish fluids and relieve symptoms. It is a suitable option for people with allergies or sensitivities to specific medications.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the US physiological saline market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Fresenius Kabi AG
• Merck KGaA
• AdipoGen Life Sciences Inc.
• Enzo Life Sciences Inc.
• Grifols SA
• Pfizer Inc
• Geno Technology Inc.
• ICU Medical Inc.
• B Braun Medical Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United States, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Physiological Saline Market based on the below-mentioned segments:

United States Physiological Saline Market, By Type

• Normal Saline
• Hypertonic Saline
• Hypotonic Saline
• Balanced Saline

United States Physiological Saline Market, By Packaging Type

• Flexible Bag
• Plastic Bottles
• Glass Bottles

United States Physiological Saline Market, By Route of Administration

• Intravenous
• Topical

United States Physiological Saline Market, By Application

• Intravenous
• Ophthalmology
• Wound Care
• Endoscopy
• Skin Abrasion
• Others